We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

6 hedge funds and large institutions have $254K invested in Enzo Biochem, Inc. in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

85% less funds holding

Funds holding: 416 (-35)

95% less capital invested

Capital invested by funds: $4.96M → $254K (-$4.71M)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 36

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
6
Holders Change
-35
Holders Change %
-85.37%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
2
Reduced
1
Closed
36
Calls
Puts
Net Calls
Net Calls Change

ENZ Hedge Fund Activity: Q2 2025 in Review

6 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2025, worth a combined $254K — down 95% from $4.96M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ENZ and 1 opened new positions — a net loss of 35 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $7.65K. The largest seller was Harbert Fund Advisors, exiting entirely with an estimated $1.92M sold.

  • 6 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2025, down from 41 in Q1 2025.
  • Funds reported $254K of Enzo Biochem, Inc. stock for Q2 2025, down 95% quarter-over-quarter.
  • 1 fund opened new Enzo Biochem, Inc. positions in Q2 2025 and 36 closed out, a net change of -35 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2025 was XTX Topco, an estimated $7.65K added.
  • The largest Enzo Biochem, Inc. seller in Q2 2025 was Harbert Fund Advisors, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2025.